Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
103.60
-0.80 (-0.77%)
Jun 27, 2025, 4:42 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
527431372133172
Market Cap Growth
43.10%16.07%179.48%-22.49%-
Enterprise Value
495394357130-
Last Close Price
107.0087.6090.0038.8052.20
PB Ratio
15.2211.2335.5125.8228.60
P/TBV Ratio
15.2211.2335.5125.8228.60
Debt / Equity Ratio
0.020.020.020.060.09
Inventory Turnover
68.53126.03---
Quick Ratio
8.0412.085.231.943.41
Current Ratio
8.2312.345.242.683.42
Return on Equity (ROE)
-70.87%-60.95%-175.28%-160.02%-
Return on Assets (ROA)
-37.63%-34.54%-85.92%-70.62%-
Return on Capital (ROIC)
-43.95%-37.80%-108.90%-93.47%-
Earnings Yield
-2.75%-3.45%-3.68%-6.71%-2.56%
FCF Yield
-3.11%-4.13%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-16.58%-15.76%-17.48%-5.54%-
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.